These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 19007882)

  • 21. Cell-based therapies for Parkinson's disease.
    Dyson SC; Barker RA
    Expert Rev Neurother; 2011 Jun; 11(6):831-44. PubMed ID: 21651331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell therapy for Parkinson's disease: Functional role of the host immune response on survival and differentiation of dopaminergic neuroblasts.
    Wenker SD; Leal MC; Farías MI; Zeng X; Pitossi FJ
    Brain Res; 2016 May; 1638(Pt A):15-29. PubMed ID: 26239914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implications of Parkinson's disease pathophysiology for the development of cell replacement strategies and drug discovery in neurodegenerative diseases.
    Pan-Montojo F; Funk RH
    CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):907-20. PubMed ID: 23131153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strategies for bringing stem cell-derived dopamine neurons to the clinic: A European approach (STEM-PD).
    Kirkeby A; Parmar M; Barker RA
    Prog Brain Res; 2017; 230():165-190. PubMed ID: 28552228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of stem cell-based therapies for Parkinson's disease.
    Zhu B; Caldwell M; Song B
    Int J Neurosci; 2016 Nov; 126(11):955-62. PubMed ID: 26824870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cell therapy for Parkinson's disease: II. Somatic stem cell-based applications].
    Anisimov SV
    Adv Gerontol; 2009; 22(1):150-66. PubMed ID: 19827685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell transplantation and gene therapy in Parkinson's disease.
    Wakeman DR; Dodiya HB; Kordower JH
    Mt Sinai J Med; 2011; 78(1):126-58. PubMed ID: 21259269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Stem cells: solution to the problem of transplants in Parkinson's disease?].
    Linazasoro G
    Neurologia; 2003 Mar; 18(2):74-100. PubMed ID: 12610757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging restorative treatments for Parkinson's disease: manipulation and inducement of dopaminergic neurons from adult stem cells.
    Zhao J; Xu Q
    CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):509-16. PubMed ID: 21495964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of transcription factors in cell replacement therapies for neurodegenerative conditions.
    Thomas M
    Regen Med; 2010 May; 5(3):441-50. PubMed ID: 20455654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stem cells and cell replacement therapy for Parkinson's disease.
    Sonntag KC; Simunovic F; Sanchez-Pernaute R
    J Neural Transm Suppl; 2009; (73):287-99. PubMed ID: 20411787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson's disease.
    Murrell W; Wetzig A; Donnellan M; Féron F; Burne T; Meedeniya A; Kesby J; Bianco J; Perry C; Silburn P; Mackay-Sim A
    Stem Cells; 2008 Aug; 26(8):2183-92. PubMed ID: 18535154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell replacement therapy for Parkinson's disease: how close are we to the clinic?
    Ganz J; Lev N; Melamed E; Offen D
    Expert Rev Neurother; 2011 Sep; 11(9):1325-39. PubMed ID: 21864078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell transplantation for the treatment of Parkinson's disease.
    Subramanian T
    Semin Neurol; 2001; 21(1):103-15. PubMed ID: 11346020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stem cell therapy for Parkinson's disease.
    Takahashi J
    Expert Rev Neurother; 2007 Jun; 7(6):667-75. PubMed ID: 17563250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neural stem cells and transplantation studies in Parkinson's disease.
    Pardal R; López-Barneo J
    Adv Exp Med Biol; 2012; 741():206-16. PubMed ID: 22457112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Derivation of functional dopamine neurons from embryonic stem cells.
    Kim DS; Kim JY; Kang M; Cho MS; Kim DW
    Cell Transplant; 2007; 16(2):117-23. PubMed ID: 17474293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cell therapy for Parkinson's disease: III. Neonatal, fetal and embryonic stem cell-based applications].
    Anisimov SV
    Adv Gerontol; 2009; 22(2):296-315. PubMed ID: 19947394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Biotherapies and Parkinson's disease].
    Cesaro P; Fenelon G; Remy P
    Rev Neurol (Paris); 2009 Nov; 165(11):857-62. PubMed ID: 19487002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.